[
    {
        "file_name": "ParatekPharmaceuticalsInc_20170505_10-KA_EX-10.29_10323872_EX-10.29_Outsourcing Agreement.pdf",
        "perturbation": [
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "16.2 Maintenance of Records\nSupplier shall maintain adequate books and records and retention samples consistent with cGMP Requirements and any other Applicable Law and requirements of applicable governmental or regulatory authorities, in respect of test records, samples and associated support data for all batches of Product Manufactured by Supplier sufficient to substantiate and verify Supplier’s duties and obligations under this Agreement for [* * *] from the expiration date of the respective Product batch.",
                "changed_text": "16.2 Maintenance of Records\nSupplier shall maintain adequate books and records and retention samples consistent with cGMP Requirements and any other Applicable Law and requirements of applicable governmental or regulatory authorities, in respect of test records, samples and associated support data for all batches of Product Manufactured by Supplier sufficient to substantiate and verify Supplier’s duties and obligations under this Agreement for one (1) year from the expiration date of the respective Product batch.",
                "explanation": "The modified text reduces the record retention period to one year. This violates the FDA's requirement for retaining batch production and control records for at least one year after the expiration date of the batch, and some records must be retained even longer (e.g., complaint files).",
                "contradicted_law": "21 CFR 211.180(a) and (e) - requiring specific records to be maintained for at least one year after the expiration date, or longer for certain records like complaint files.",
                "location": "Article 16.2"
            }
        ]
    }
]